Europe Circulating Tumor Cell (CTC) Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)

No. of Pages: 139    |    Report Code: TIPRE00028647    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Circulating Tumor Cell (CTC) Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Circulating Tumor Cell (CTC) Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Circulating Tumor Cell (CTC) Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising cancer prevalence worldwide
  • 5.1.3 Increased demand for non-invasive diagnostics
  • 5.1.4 Advancements in CTC detection technologies
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Expansion in liquid biopsy applications
  • 5.2.3 Development of AI-driven diagnostics
  • 5.2.4 Growth in personalized cancer treatments
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Use of microfluidics in CTC isolation
  • 5.3.3 Increased focus on predictive analytics
  • 5.3.4 Integration with next-generation sequencing
5.4 Impact of Drivers and Restraints

6. Europe Circulating Tumor Cell (CTC) Diagnostics Market Regional Analysis

6.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Overview
6.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Forecast Analysis

7. Europe Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Technology

7.1 CTC Detection and Enrichment Method
  • 7.1.1 Overview
  • 7.1.2 CTC Detection and Enrichment Method: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 CTC Direct Detection Method
  • 7.2.1 Overview
  • 7.2.2 CTC Direct Detection Method: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 CTC Analysis
  • 7.3.1 Overview
  • 7.3.2 CTC Analysis: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Application

8.1 Clinical/Liquid Biopsy
  • 8.1.1 Overview
  • 8.1.2 Clinical/Liquid Biopsy: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Research
  • 8.2.1 Overview
  • 8.2.2 Research: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by End-User

9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Research: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Research and Academic Institutes
  • 9.2.1 Overview
  • 9.2.2 Research: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Diagnostic Centers
  • 9.3.1 Overview
  • 9.3.2 Research: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Circulating Tumor Cell (CTC) Diagnostics Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
    • 10.1.1.1.2 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
  • 10.1.1.2 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
    • 10.1.1.2.2 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
  • 10.1.1.3 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
    • 10.1.1.3.2 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
  • 10.1.1.4 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
    • 10.1.1.4.2 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
  • 10.1.1.5 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
    • 10.1.1.5.2 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
  • 10.1.1.6 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
    • 10.1.1.6.2 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Circulating Tumor Cell (CTC) Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Stemcell Technologies Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Qiagen
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Screencell
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ikonisys, Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Fluxion Biosciences
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Thermo Fisher Scientific Inc.
  2. Stemcell Technologies Inc.
  3. Qiagen
  4. Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  5. Screencell
  6. Ikonisys, Inc
  7. Fluxion Biosciences
  8.  
europe-circulating-tumor-cell-ctc-diagnostics-market